Final Career Stage Analyses of Applications Submitted During the Pandemic (Part 7)

July 10, 2023

The HHS-declared public health emergency for COVID-19 ended on May 11, 2023 (NOT-OD-23-095). With this milestone, we are also closing out our series of blogs on the distributions of gender and race of designated principal investigators (PIs) of R01 and RPG applications submitted before and after the onset of the pandemic. This final post builds on previous … Continue reading “Final Career Stage Analyses of Applications Submitted During the Pandemic (Part 7)”

More Early Stage Investigators Supported in FY 2022

June 5, 2023

Over the past two years, we supported 1,412 early stage investigators (ESIs) in fiscal year (FY) 2020 and 1,513 in FY 2021, which were both all-time highs. These ESIs were first-time Principal Investigators (PIs) designated on type 1 (new) R01-equivalent awards. Today, we are pleased to announce that even more ESIs were supported in FY 2022 as part of our continued Next Generation Researchers Initiative (NGRI) efforts.

Pilot Starting May 15 to Improve NIH R&D Contracts Project Data

May 3, 2023

NIH is launching a pilot on May 15, 2023, to improve the quality, accuracy, and transparency of project data for awarded NIH R&D contracts to promote the highest level of public accountability (see NIH Guide Notice NOT-OD-23-115). Six contract vendors have been selected to participate in the pilot. These vendors will directly enter select project data … Continue reading “Pilot Starting May 15 to Improve NIH R&D Contracts Project Data”